Host factor requirements for different classes of viruses are still to be fully unraveled. Replication of the viral genome and synthesis of viral proteins inside the human host cell are associated with altered, often enhanced, cellular metabolism and increased demand for nutrients as well as specific metabolites. With more than 400 members listed to date in humans, solute carriers (SLCs) represent the largest family of transmembrane proteins dedicated to the transport of ions and small molecules such as amino acids, sugars and nucleotides. Consistent with their impact on cellular metabolism, several SLCs have been implicated as host factors affecting the viral life cycle and the cell response to infection. In this study, we aimed at characterizing the role of host SLCs in cell survival upon viral infection by performing unbiased genetic screens using a focused CRISPR knockout library. Genetic screens with the cytolytic vesicular stomatitis virus (VSV) showed that loss of two SLCs genes, encoding the sialic acid transporter SLC35A1/CST and the zinc transporter SLC30A1/ZnT1, affected cell survival upon infection. Further characterization of these genes pointed to a role of both transporters in the apoptotic response induced by VSV, offering new insights into the cellular response to oncolytic virus infections.
Introduction
Solute carriers (SLCs) comprise the largest family of transporters in the human genome and the second largest family of transmembrane proteins after G-protein coupled receptors (GPCRs). As such, they represent the major "gatekeepers" of energy supply and metabolism in a cell, controlling the uptake and release of a growing list of small molecules and metabolites 1 . With more than 400 members, SLCs are a significantly understudied family considering that ~30% of family members still have completely unknown function(s) or substrate specificity, despite a large number of links between SLCs and human diseases 1, 2 .
Viruses represent a major class of pathogens affecting human health and act as potent and pleiotropic perturbations of cellular metabolism and function, offering the possibility to explore the biology of cellular and immunological processes. Given their complete dependence on host metabolism for replication, viruses have been shown to dramatically alter and exploit cellular pathways for their own purpose 3 . Accordingly, transporters have been shown to be modulated during virus infection 4 , are required as viral entry receptors 5, 6 or as factors affecting viral cell entry 7, 8 . Finally, solute carriers can play important roles in determining the outcome of anti-viral immune responses 9, 10 .
In this study, we used an unbiased genetic screening approach to identify transporters affecting infectivity and cellular survival upon treatment with influenza virus (IAV) or vesicular stomatitis virus (VSV). In particular, we focus on VSV, which has been extensively used as a model system for virus replication and viral life cycle studies 11 . A cytolytic virus, VSV is able to induce rapidly and effectively cell death. Apoptosis is induced either via the mitochondrial intrinsic pathway via caspase-9 activation, via death receptor-mediated (extrinsic pathway) apoptosis or via ER-stress mediated apoptosis
12
. Due to its non-pathogenicity in humans and its ability to rapidly induce apoptosis in infected cancer cells, VSV has been showing promise in cancer immunotherapies 13 and oncolytic virotherapies 12 , as well as for the development of vaccines e.g. against Ebola virus 14 . Therefore, there is significant interest in determining the host factors affecting cell survival upon VSV infection. Here we describe two transporters, the sialic acid transporter SLC35A1 and the zinc transporter SLC30A1 (ZnT1), as factors promoting resistance or sensitivity upon VSV infection, respectively.
Results

A SLC-focused CRISPR knockout genetic screen identifies SLC35A1 and SLC35A2 as factors required for IAV infection
In order to identify solute carriers affecting viral infection and cell survival, we performed unbiased genetic screens using a SLC-focused CRISPR knockout (KO) lentiviral library targeting 388 SLC genes with multiple sgRNAs per gene 15 (Fig 1a) . To test the ability of this library to identify factors affecting viral infection, we screened for transporters affecting survival of the lung adenocarcinoma cell line Fig 1a) , and good correlations between replicates (Suppl Fig 1b) . Consistent with previous results
16,17
, we identified two SLC genes, SLC35A1 and SLC35A2, whose sgRNAs were significantly enriched in the surviving cell population (Fig 1b, Suppl Table 1 ). Both genes are members of the large SLC35 family of nucleotide-sugar transporters and the two corresponding proteins localize to the Golgi apparatus
18
. SLC35A1/CST is a CMP-sialic acid/CMP antiporter while SLC35A2 is a UDPgalactose/UDP antiporter. IAV exploits sialic acid, a hexose residue present on several oligosaccharides, as its main cell entry receptor
19
. These transporters have been previously shown to play an important role in determining the glycosylation pattern of secreted and plasma membrane proteins and are associated with congenital disorders of glycosylation 20, 21 . In particular, lack of SLC35A1 or SLC35A2
(which results in the loss of the galactose residue often present upstream of the terminal sialic acid) has been shown to cause reduced or abolished levels of sialyation on the cell surface, resulting in a severe impairment of IAV docking and entry 16, 17 . Consistent with the screening results, CRISPR/Cas9-based knockout of the SLC35A1 or SLC35A2 genes in A549 cells resulted in increased resistance to IAV infection (Fig 1c, Suppl Fig1c-d) . The SLC35A1 inactivation effect could be reversed by ectopic expression of SLC35A1 (Fig 1c, Suppl. Fig 1e) , confirming the dependence of the observed phenotype on this specific gene. Altogether, this set of experiments validated the use of our SLC-focused CRISPR knockout library as well as our experimental approach to investigate the role of SLC genes in the viral life cycle in tissue-cultured cells. Moreover, it confirmed the non-redundant role of members A1 and A2 of the SLC35 family, among all other SLCs represented in the library, on determining the ability of influenza A viruses to infect human cells.
Genetic screening identifies SLC35A1 and SLC30A1 as modulators of cell survival upon VSV infection.
A549 cells showed substantial cell death 24 hours post VSV infection (above 50% at MOI 10) (Suppl Fig 1f) . For the genetic screen, A549 cells were infected with the SLC library and subsequently infected with VSV virus at a MOI of 10 (Fig 1a) . Samples were collected pre-infection and at 48 h.p.i. As before, we observed good representation of the library in all samples ( Suppl Fig 1g) , and good correlations between replicates (Suppl Fig 1h) . Comparison of the sgRNA abundance between the virus-treated and control samples at 48h showed a moderate but significant differential enrichment for two transporters:
SLC30A1 (ZnT1, log2 fold change: 0.373, adjusted p-value: 7x10 -6 ) and SLC35A1 (log2 fold change: -0.362, adjusted p-value: 1.5x10 -4 ) (Fig 1d) . Interestingly loss of SLC35A1, which conferred resistance in the IAV screen, resulted in increased cell sensitivity upon VSV infection. Moreover, we identified as a permissive factor SLC30A1, the only member of the SLC30 family reported to export zinc at the plasma membrane
22
. In order to validate these results, we used a multicolor competition assay (MCA) approach in A549 cells carrying sgRNAs targeting SLC30A1, SLC35A1 or expressing a sgRNA targeting Renilla luciferase as negative control. We observed a modest but clear enrichment of cells carrying SLC30A1 mutations compared to control cells at both 24 and 48 hours after infection, validating the outcome of the screen and suggesting that indeed SLC30A1 is exerting a negative effect on cell survival after VSV infection (Fig 1e, Suppl Fig 1i) . Conversely, inactivation of the SLC35A1 gene resulted in increased cell death compared to control at 48 hours, suggesting that this transporter support cell survival after VSV infection thereby validating the primary screen (Fig 1f, Suppl Fig 1j) .
Loss of the Zn-exporter SLC30A1 inhibits caspase activation upon VSV virus infection
SLC30A1 has been reported to be responsible for the export of zinc from the cytoplasm 22, 23 . To confirm its role in the homeostasis of zinc levels in our cellular system, we measured intracellular levels of zinc using the Zinpyr1 dye
24
. A549 cells lacking SLC30A1 ( Suppl Fig 2a) or a single-cell-derived HAP1 SLC30A1 KO clone (∆SLC30A1_1777_10) showed increased levels of zinc compared to control cell lines (Fig 2a, Suppl Fig 2b) . This effect was reversed by ectopic expression of SLC30A1 (Fig 2a, Suppl   Fig 2c-d) in the HAP1 SLC30A1-deficient cells. Moreover, a mutant SLC30A1, defective in its transport activity (D254A_H43A) 25 , failed to decrease the intracellular zinc levels (Fig 2a) despite localizing preferentially to the plasma membrane, similar to the WT protein ( Suppl Fig 2c- . Since VSV is a cytolytic virus, able to kill infected cells via induction of apoptosis through both intrinsic and extrinsic pathways
12
, we speculated that elevated intracellular zinc levels might interfere with the activation of pro-apoptotic signalling through inhibition of caspases. To experimentally verify this hypothesis, we monitored the cleavage of different apoptotic caspases in VSV-infected A549 and HAP1 cells (Fig 2b-c) . Indeed, A549 cells lacking the SLC30A1 transporter had impaired levels of all expressed and cleaved caspases tested (caspase-3, -7, -9) (Fig 2b) . This effect was even more pronounced in the HAP1 SLC30A1-deficient clone (Fig 2c) . Consistent with diminished caspase activation, we observed reduced number of Annexin V-positive SLC30A1 KO cells compared to WT A549 cells (Fig 2d) . In line with this data, we observed a reduction of Annexin V-positive cells upon VSV infection in WT cells supplemented with Zn 2+ (ZnCl2 concentrations above 100mM) (Fig 2e) .
Altogether, these data show that loss of SLC30A1 in A549 and HAP1 cells results in increased intracellular levels of Zn 2+ and that cells lacking this transporter, upon VSV infection, show reduced caspases activation and apoptotic cell death.
SLC30A1-deficient cells show reduced infectivity in multi cycle infections
We next tested whether loss of SLC30A1 affected susceptibility to VSV infection in term of entry and . Given the well described role of Zn 2+ ions and other zinc transporters in the immune response against different pathogens and inflammatory stimuli
31
, we set to test whether SLC30A1 loss may affect the antiviral immune response against VSV infection. Wild-type VSV virus does not generally elicit strong immune responses (Fig 3d) . In contrast, VSV harbouring mutations in the matrix (M) protein create an attenuated form that fails to shut down host cell innate immune signalling efficiently and therefore elicits a stronger immune response. One of these mutants, VSV-∆M51-GFP
32
, caused a readily measurable response upon infection of HAP1 WT cells at low MOI, as monitored by phosphorylation of IRF3 and STAT1 transcription factors (Fig 3d) . Similar to WT VSV, loss of SLC30A1 resulted in reduced infectivity upon treatment with VSV-∆M51-GFP (Suppl Fig 3e) .
However, cells deficient for SLC30A1 did not show notable differences in the activation of IFNα/β and NF-κB pathways, two of the major antiviral immune response pathways, compared to wild type cells (Fig 3d) . Moreover, we did not detect differences at early hours post infection in either accumulation of viral RNA (0.5-4h) or viral protein (i.e. VSV-G, 6h) (Fig 3e-f) . Interestingly, when measuring the titers of virus produced by the SLC30A1 knockout cells compared to HAP1 WT we did measure a strong reduction in the number of viral particles released from the SLC30A1-deficient cells (Fig 3g) . This is consistent with the reduced amount of viral RNA in the SLC30A1-deficient cells at the later stages of the infection (≥4 hours), when the reinfection with the produced viral particles starts to occur (Fig 3e) .
Together, these observations suggest that SLC30A1-deficiency affects VSV at late stages of the virus life cycle. Overall, we did not observe effects on cell infectivity or immune response due to SLC30A1-loss under single-cycle conditions (high MOI). Interestingly, SLC30A1-deficient cells produced reduced titers of virus after infection, likely to be due to a defect at the late stage of the virus cycle, which could become relevant in a multicycle experiments.
Loss of SLC35A1 results in increased cell death and apoptosis upon VSV infection
The sialic acid-CMP transporter SLC35A1 has been previously shown to be involved in the cellular response to apoptotic stimuli. In particular, SLC35A1 loss has been reported to evoke an elevated Golgi stress response 31 resulting in increased rates of pro-apoptotic signalling in the cells [32] [33] [34] . We therefore hypothesised that loss of SLC35A1 may result in sensitisation to cell death induction upon VSV infection as well as upon other stimuli. Indeed, we observed that A549 and HAP1 cells lacking SLC35A1 ( Suppl Fig 4a) show an elevated cell death and apoptotic response in response to VSV infection, as monitored by increased number of Annexin V-positive cells (Fig 1f, 4a, Suppl Fig 1j) and increased caspase cleavage that could be partially reversed by ectopic overexpression of SLC35A1
( Suppl Fig 4b-c) suggesting a dependency on SLC function. Cell death was similarly observed upon stimulation with compounds previously reported to induce a Golgi stress response such as Brefeldin A
35
( Suppl Fig 4d) . However, in cells lacking SLC35A1 we did not observe an increase in MAPK pathway activity or ARF4 protein previously reported to indicate a response to Golgi stress (Fig 4b) 
, suggesting involvement of alternative pathway(s). Consistent with this, we found that SLC35A1 knockout cells were also more sensitive to two additional, non-Golgi stress-related, cytotoxic compounds: the topoisomerase inhibitor camptothecin and the proteasome inhibitor carfilzomib (Suppl Fig 4d) .
Interestingly, SLC35A1 KO cells show increased infection rates in multi-cycle infections in several different cell lines (Fig 4c, Suppl Fig 4e) . This effect could also be reverted by re-expression of SLC35A1 (Fig 4d) . Finally, in experiments following a single infection cycle, we detected increased virus titers in SLC35A1 KO cells compared to wild type cells as measured by FACS (Fig 4e) . Altogether, these data point to a combination of a more pronounced apoptotic response and an increased rate of VSV replication, as indicated by the higher virus titers produced in cells lacking SLC35A1, as factors contributing to its role in cellular survival upon viral infection.
Discussion
Functional genomic and genetic screens, based on siRNA, insertional mutagenesis and, more recently, CRISPR/Cas9, have been extremely valuable in identifying host factors affecting viral infectivity and replication, in particular regarding entry factors 16, 17, [36] [37] [38] . However, the role of metabolic genes and transporters as host genes affecting the viral life cycle and host cell survival upon infection remain relatively understudied. Here we employed SLC-focused CRISPR knockout screens to identify two solute carriers, the CMP-sialic acid/CMP transporter SLC35A1/CST and the zinc transporter SLC30A1/ZnT1 as critical host factors affecting in opposite ways the survival of human cell lines towards infection with the oncolytic VSV virus (Fig 1) . We confirmed that SLC30A1 is a zinc exporter localized at the plasma membrane and that genetic inactivation resulted in increased intracellular zinc levels and increased resistance to VSV-induced cellular killing (Fig1-2) . Mechanistically, loss of SLC30A1 did not appear to affect the anti-viral immune response or viral entry (Fig3). We instead observed a reduced infection of SLC30A1-deficient cells compared to WT cells in multi-cycle infections.
This phenotype was coupled to reduced virus titers, potentially hinting towards a defect in the later stages of the viral cycle (Fig3). More importantly, upon SLC30A1 inactivation we observed a marked reduction of caspase activation and, consequently, reduced apoptotic cell death (Fig 2) . Given the known role of Zn 2+ ions as pan-caspase inhibitors [26] [27] [28] , we hypothesise that loss of SLC30A1, and the resulting increased intracellular Zn 2+ levels, result in an apoptosis-resistant state and an accompanying increased survival upon further perturbation such as VSV infection.
The second transporter gene identified in our VSV screen, the Golgi-residing SLC35A1, has previously been implicated in IAV infectivity due to its critical role in the addition of sialic acid, the major receptor of influenza virus, to proteins and lipids on the cell surface 39, 40 . When we screened for solute carriers affecting infectivity to IAV, we identified not only SLC35A1 but also the related transporter SLC35A2, a UDP-galactose/UDP transporter, as hits (Fig 1) . Both genes were separately identified in genomewide screens 16, 17 as host factors required for IAV infectivity and recapitulated in our screen. Unlike the observation with IAV, loss of SLC35A1 resulted in increased apoptotic cell death upon VSV infection (Fig 1, 4) . However, we did not observe activation of signalling pathways commonly associated with the induction of Golgi stress, a pro-apoptotic pathway previously shown to be linked to SLC35A1 31 . It was formerly described that sialic acid modifications play important roles for various pro-apoptotic signals [41] [42] [43] as well as prevent apoptosis induced by galectins 42 . Further studies will be required to characterize which pathway(s) are involved in VSV-and SLC35A1-dependent cell death and viral phenotypes.
In conclusion, we used an unbiased SLC-focused genetic approach to identify transporter proteins 
CRISPR-KO screening
The human SLC knockout CRISPR/Cas9 library been described previously 15 . Viral particles were prepared by transient transfection of low passage, subconfluent HEK293T cells with the library plasmid pool together with packaging plasmids psPAX2 (Addgene #12260) and pMD2.G (Addgene #12259) using PolyFect (Qiagen). After 24 hours the media was changed to fresh RPMI media supplemented with 10% FCS and antibiotics. The viral supernatant was collected after 48 hours, filtered (0.45 μm) and stored at -80°C until further use.
A549 cells were infected with the SLC knockout library at a multiplicity of infection of 0.2-0.3 and screened after selection for 5 days with puromycin (2 μg/mL) and 2 days of recovery and expansion.
For the screen, 8x10 6 (equals ~2000x coverage) of A549 cells were seeded in duplicates and infected with IAV-WSN and VSV-GFP at the MOI of 0.5 and 10 respectively. Cells were collected 96 hours post infection (for the IAV-WSN screen) and at 48h hours post infection (for the VSV-GFP screen)
together with time matching uninfected controls. Additionally, time 0 samples were collected at the time of infection. Genomic DNA was extracted using the DNAeasy kit (Qiagen) and amplified with 2 rounds of PCR using primers derived from Shalem et al. 47 and modified to allow dual indexing by addition of an additional barcode on the forward primers. The PCR-amplified samples were sequenced on a HiSeq2500 (Illumina) at the Biomedical Sequencing Facility (CeMM/MUW).
Screen analysis
Sequencing reads were matched to the sgRNA library sequences and counted using an in-house script.
One sample was removed from the analysis because of low coverage (median of less than 50 reads per sgRNA). Guide-level read tables were input to a gene-level DESeq2 model 48 . Custom normalization factors were provided assuring equal median sgRNA read per sample. As the gene-level model included the effect of the guides, identical number of guides (i.e. 6) per gene were required across all genes.
Therefore, for 10 genes with only 5 guides in the library, a randomly selected guide was duplicated, and six guides were randomly selected for 3 genes with more than 6 guides in the library as well as the for the negative control. The model was tested for differential abundance contrasting virus-infected samples versus the uninfected control samples of corresponding time points. Genes with a multiple-testing adjusted p-value 49 of less than 0.1 (adj. p-value <0.1) were considered significantly enriched or depleted, corresponding to an estimated false-discovery rate below 10%.
Plasmids and knockout cell lines generation
For CRISPR-based knockout cell lines, sgRNAs were designed using CHOPCHOP 50 and cloned into pLentiCRISPRv2 (Addgene, #52961), pLentiCRISPRv3 51 , pX459, LGPIG (pLentiGuide-PuroR-IRES-GFP) or LGPIC (pLentiGuide-PuroR-IRES-mCherry) 52 . sgRen targeting Renilla luciferase cDNA was used as negative control sgRNA 52 (Suppl Table 2 ). SLC35A1 (HsCD00415788) and SLC30A1 (HsCD00375357) cDNAs were obtained as gateway-compatible pENTR vectors from the Harvard PlasmID Repository. sgRNA-resistant cDNA versions as well as the SLC30A1 D254A_H43A double mutant 25 were generated using NEB Q5 site-directed mutagenesis kit (Suppl Table 2 ). cDNAs were transferred into gateway-compatible lentiviral expression vectors pLX304 (Addgene, #25890, CMV promoter driven expresion) or pRRL (described previously 52 , EF1a promotor driven expression) using LR recombination (ThermoFisher Scientific).
For generation of lentiviral knockout and overexpression cells HEK293T cells were transfected with psPAX2 (Addgene #12260) and pMD2.G (Addgene #12259) and expression vectors using Polyfect (Qiagen). 24 hours post transfection medium was replaced with fresh medium that was harvested 48
hours later, filtered (0.45 μm), supplemented with 5μg/mL Polybrene (Hexadimethrine bromide, Sigma) and added to target cells. 48 hours after transduction the medium was supplemented with the respective selection antibiotics. Cells were selected for 5-7 days. Due to the downregulation of the expression of wild type cDNA of SLC30A1 over time, fresh overexpression cells were prepared every 2-3 weeks.
Editing efficiency of sgRNAs was assessed by Sanger sequencing followed by analysis of sequencing results with TIDE web tool 53 .
Flow cytometry
For flow cytometric analyses of virus-infected cells, cells were seeded into 24-well plates and infected with IAV or VSV at the specified MOIs. Cells were collected at indicated time points and fixed with 4% PFA in PBS. IAV-WSN/1933 infected cells were permeabilized (PBS, 0.1% Triton X-100), stained with AlexaFluor-488-labelled (ThermoFisher Scientific) anti-influenza nuclear protein antibody (ab20343, Abcam) for 1 hour at room temperature followed by two washing steps.
In order to determine the amount of dead or apoptotic cells after virus infection, cells were seeded into 12-well plates, infected at specified MOIs, and at the indicated time points. Depending on the cells prepared for staining, cells were stained with AnnexinV-FITC (eBioscience) or AnnexinV-AF647
(eBioscience), Live/Dead Red or Green fixable dyes (Invitrogen) or Propidium Iodide (PI) for 15min
(AnnexinV and PI) or 30min (Live/Dead) at room temperature, fixed with 4% PFA and subsequently analysed by flow cytometry.
For the measurement of intracellular Zn 2+ levels cells were incubated for 30min at 37°C in serum-free IMDM supplemented with 2mM EDTA and 50µM Zipyr 1 (Abcam, ab145349).
Flow cytometry-based multi-color competition assay (MCA) was performed as described previously 
RNA isolation and qRT-PCR
For qRT-PCR measurement of viral RNA (vRNA), cells were infected with VSV-GFP at MOI 20 and at the indicated time points total RNA was isolated from the samples using RNeasy Kit (Qiagen). RNA was reverse transcribed using random hexamer primers and RevertAid Reverse Transcriptase (Fermentas). qRT-PCR was performed using SensiMix SYBR Green (Bioline) on a QIAGEN RotorGene Q. Results were normalized to the levels of the housekeeping gene GAPDH (Suppl. Table 2 ).
Viral titer measurement
For the measurement of virus progeny, cells were infected with VSV-GFP at MOI of 2. After incubation with infectious media for 30min at 37°C, cells were subsequently washed with PBS and media replaced with full IMDM for the remaining duration of the experiment (8 hours in total). Media, containing viral particles, was serially diluted and added to fresh HAP1 wild type cells. Cells were further incubated for 5 hours and the percentage of infected cells was analysed by flow cytometry. Viral titer was calculated using the following formula: U/mL = (cell number * % of GFP + cells) / (volume of virus containing media * dilution factor).
Antibodies and Immunoblotting
The following antibodies were used: V5 (Invitrogen, R960 For immunoblotting whole cell extracts were prepared using RIPA lysis buffer (25mM Tris/HCl pH 7.6, 150mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS and one tablet of EDTA-free protease inhibitor (Roche) per 50 mL) supplemented with Halt phosphatase inhibitor cocktail (Thermo Fisher Scientific #78420) and Benzonase (71205, EMD Millipore). Protein extracts were normalized using the Bradford assay (Bio-Rad). Cell lysates were run on SDS-polyacrylamide gel and transferred to nitrocellulose membranes Protran BA 85 (GE Healthcare). The membranes were incubated with the antibodies indicated above and visualized with horseradish peroxidase-conjugated secondary antibodies using the ECL Western blotting system (Thermo Scientific).
Immunofluorescence
For immunofluorescence detection of subcellular localisation of overexpressed SLC30A1 WT and mutant fused to mScarlet in HAP1 wild type cells, cells were seeded onto poly-L-lysine hydrobromide (P6282, Sigma-Aldrich)-coated 96-well CellCarrier Ultra plates (PerkinElmer). After an attachment period, cells were stained for the measurement of the intracellular Zn 2+ levels as described above. Images were acquired on the Opera Phenix automated spinning disk confocal microscope (PerkinElmer). 
Figure legends
